{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T18:26:04Z","timestamp":1790619964801,"version":"4.1.0"},"reference-count":76,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2023,10,3]],"date-time":"2023-10-03T00:00:00Z","timestamp":1696291200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,10,3]],"date-time":"2023-10-03T00:00:00Z","timestamp":1696291200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Cell Biochem"],"published-print":{"date-parts":[[2024,9]]},"DOI":"10.1007\/s11010-023-04859-0","type":"journal-article","created":{"date-parts":[[2023,10,3]],"date-time":"2023-10-03T16:03:05Z","timestamp":1696348985000},"page":"2245-2254","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["LOX-1 variants modulate the severity of cardiovascular disease: state of the art and future directions"],"prefix":"10.1007","volume":"479","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1333-0423","authenticated-orcid":false,"given":"Valter","family":"Lubrano","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvana","family":"Balzan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela","family":"Papa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,10,3]]},"reference":[{"key":"4859_CR1","doi-asserted-by":"publisher","first-page":"1775","DOI":"10.1161\/STROKEAHA.113.001238","volume":"44","author":"G Xu","year":"2013","unstructured":"Xu G, Ma M, Liu X, Hankey GJ (2013) Is there a stroke belt in China and why? Stroke 44:1775\u20131783. https:\/\/doi.org\/10.1161\/STROKEAHA.113.001238","journal-title":"Stroke"},{"key":"4859_CR2","first-page":"927","volume":"5","author":"M Rafieian-Kopaei","year":"2014","unstructured":"Rafieian-Kopaei M, Setorki M, Doudi M, Baradaran A, Nasri H (2014) Atherosclerosis: process, indicators, risk factors and new hopes. Int J Prev Med 5:927\u2013946","journal-title":"Int J Prev Med"},{"key":"4859_CR3","doi-asserted-by":"publisher","first-page":"4674","DOI":"10.1016\/j.bmc.04.031","volume":"15","author":"KS Jain","year":"2007","unstructured":"Jain KS, Kathiravan MK, Somani RS, Shishoo CJ (2007) The biology and chemistry of hyperlipidaemia. Bioorg Med Chem 15:4674\u20134699. https:\/\/doi.org\/10.1016\/j.bmc.04.031","journal-title":"Bioorg Med Chem"},{"key":"4859_CR4","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/S0140-6736(16)30677-8","volume":"389","author":"GW Reed","year":"2017","unstructured":"Reed GW, Rossi JE, Cannon CP (2017) Acute myocardial infarction. Lancet 389:197\u2013210. https:\/\/doi.org\/10.1016\/S0140-6736(16)30677-8","journal-title":"Lancet"},{"key":"4859_CR5","doi-asserted-by":"publisher","first-page":"1397","DOI":"10.1016\/S0140-6736(14)61368-4","volume":"385","author":"J Fulcher","year":"2015","unstructured":"Fulcher J, O\u2019Connell R, Voysey M et al (2015) Efficacy and safety of LDL-lowering therapy among men and women: meta-analysis of individual data from 174,000 participants in 27 randomised trials. Lancet 385:1397\u20131405. https:\/\/doi.org\/10.1016\/S0140-6736(14)61368-4","journal-title":"Lancet"},{"key":"4859_CR6","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1038\/386073a0","volume":"386","author":"T Sawamura","year":"1997","unstructured":"Sawamura T, Kume N, Aoyama T et al (1997) An endothelial receptor for oxidized low-density lipoprotein. Nature 386:73\u201377. https:\/\/doi.org\/10.1038\/386073a0","journal-title":"Nature"},{"key":"4859_CR7","doi-asserted-by":"publisher","first-page":"16740","DOI":"10.1038\/srep16740","volume":"5","author":"S Thakkar","year":"2015","unstructured":"Thakkar S, Wang X, Khaidakov M et al (2015) Structure-based design targeted at LOX-1, a receptor for oxidized low-density lipoprotein. Sci Rep 5:16740. https:\/\/doi.org\/10.1038\/srep16740","journal-title":"Sci Rep"},{"key":"4859_CR8","doi-asserted-by":"publisher","first-page":"12633","DOI":"10.1074\/jbc.275.17.12633","volume":"275","author":"L Cominacini","year":"2000","unstructured":"Cominacini L, Pasini AF, Garbin U et al (2000) Oxidized low density lipoprotein (ox-LDL) binding to ox-LDL receptor-1 in endothelial cells induces the activation of NF-kappaB through an increased production of intracellular reactive oxygen species. J Biol Chem 275:12633\u201312638. https:\/\/doi.org\/10.1074\/jbc.275.17.12633","journal-title":"J Biol Chem"},{"key":"4859_CR9","doi-asserted-by":"publisher","first-page":"1337","DOI":"10.1161\/CIRCRESAHA.107.151704","volume":"100","author":"Y Wen","year":"2007","unstructured":"Wen Y, Leake DS (2007) Low density lipoprotein undergoes oxidation within lysosomes in cells. Circ Res 100:1337\u20131343","journal-title":"Circ Res"},{"key":"4859_CR10","doi-asserted-by":"publisher","first-page":"1735","DOI":"10.1016\/S0891-5849(00)00231-8","volume":"28","author":"PL Fox","year":"2000","unstructured":"Fox PL, Mazumder B, Ehrenwald E, Mukhopadhyay CK (2000) Ceruloplasmin and cardiovascular disease. Free Radical Biol Med 28:1735\u20131744","journal-title":"Free Radical Biol Med"},{"key":"4859_CR11","doi-asserted-by":"publisher","first-page":"1825","DOI":"10.1111\/j.1538-7836.2005.01370.x","volume":"3","author":"R Stocker","year":"2005","unstructured":"Stocker R, Keaney KJ (2005) Jr New insights on oxidative stress in the artery wall. J Throm Haem 3:1825\u20131834","journal-title":"J Throm Haem"},{"key":"4859_CR12","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1007\/s11883-012-0228-1","volume":"14","author":"T Goyal","year":"2012","unstructured":"Goyal T, Mitra S, Khaidakov M et al (2012) Current concepts of the role of oxidized LDL receptors in atherosclerosis. Curr Atheroscler Rep 14:150\u2013159. https:\/\/doi.org\/10.1007\/s11883-012-0228-1","journal-title":"Curr Atheroscler Rep"},{"key":"4859_CR13","doi-asserted-by":"publisher","DOI":"10.1155\/2012\/632408","author":"MW Twigg","year":"2012","unstructured":"Twigg MW, Freestone K, Homer-Vanniasinkam S, Ponnambalam S (2012) The LOX-1 scavenger receptor and its implications in the treatment of vascular disease. Cardiol Res Pract. https:\/\/doi.org\/10.1155\/2012\/632408","journal-title":"Cardiol Res Pract"},{"key":"4859_CR14","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1161\/01.res.83.3.32812","volume":"83","author":"T Murase","year":"1998","unstructured":"Murase T, Kume N, Korenaga R et al (1998) Fluid shear stress transcriptionally induces lectin-like oxidized LDL receptor-1 in vascular endothelial cells. Circ Res 83:328\u2013333. https:\/\/doi.org\/10.1161\/01.res.83.3.32812","journal-title":"Circ Res"},{"key":"4859_CR15","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1007\/s11010-013-1770-z","volume":"383","author":"V Lubrano","year":"2013","unstructured":"Lubrano V, Balzan S (2013) LOX-1, a new marker of risk and prognosis in coronary artery disease? Mol Cell Biochem 383:223\u2013230. https:\/\/doi.org\/10.1007\/s11010-013-1770-z","journal-title":"Mol Cell Biochem"},{"key":"4859_CR16","doi-asserted-by":"publisher","unstructured":"Rizzacasa B, Morini E, Pucci S, Murdocca M, Novelli G, Amati F. (2017) LOX-1 and Its Splice Variants: A New Challenge for Atherosclerosis and Cancer-Targeted Therapies. Int J Mol Sci. Jan 29;18(2):290. doi: https:\/\/doi.org\/10.3390\/ijms18020290)","DOI":"10.3390\/ijms18020290"},{"key":"4859_CR17","doi-asserted-by":"publisher","first-page":"3146","DOI":"10.1161\/01.CIR.0000074207.85796.36","volume":"107","author":"Q Chen","year":"2003","unstructured":"Chen Q, Reis SE, Kammerer C et al (2003) Genetic variation in lectin-like oxidized low-density lipoprotein receptor 1 (LOX1) gene and the risk of coronary artery disease. Circulation 107:3146\u20133151. https:\/\/doi.org\/10.1161\/01.CIR.0000074207.85796.36","journal-title":"Circulation"},{"key":"4859_CR18","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1016\/s0014-5793(01)03325-7","volume":"511","author":"T Jono","year":"2002","unstructured":"Jono T, Miyazaki A, Nagai R, Sawamura T, Kitamura T, Horiuchi S (2002) Lectin-like oxidized low density lipoprotein receptor-1 (LOX-1) serves as an endothelial receptor for advanced glycation end products (AGE). FEBS Lett 511:170\u2013174. https:\/\/doi.org\/10.1016\/s0014-5793(01)03325-7","journal-title":"FEBS Lett"},{"key":"4859_CR19","doi-asserted-by":"publisher","first-page":"2759","DOI":"10.1016\/j.jacc.2017.04.010","volume":"69","author":"NVK Pothineni","year":"2017","unstructured":"Pothineni NVK, Karathanasis SK, Ding Z, Arulandu A, Varughese KI, Mehta JL (2017) LOX-1 in atherosclerosis and myocardial ischemia: biology, genetics, and modulation. J Am Coll Cardiol 69:2759\u20132768. https:\/\/doi.org\/10.1016\/j.jacc.2017.04.010","journal-title":"J Am Coll Cardiol"},{"key":"4859_CR20","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.cardiores.2005.09.006","volume":"69","author":"JL Mehta","year":"2006","unstructured":"Mehta JL, Chen J, Hermonat PL, Romeo F, Novelli G (2006) Lectin-like, oxidized low-density lipoprotein receptor-1 (LOX-1): a critical player in the development of atherosclerosis and related disorders. Cardiovasc Res 69:36\u201345. https:\/\/doi.org\/10.1016\/j.cardiores.2005.09.006","journal-title":"Cardiovasc Res"},{"key":"4859_CR21","doi-asserted-by":"publisher","first-page":"3110","DOI":"10.1161\/01.cir.99.24.3110","volume":"99","author":"H Kataoka","year":"1999","unstructured":"Kataoka H, Kume N, Miyamoto S et al (1999) Expression of lectin like oxidized low-density lipoprotein receptor-1 in human atherosclerotic lesions. Circulation 99:3110\u20133117. https:\/\/doi.org\/10.1161\/01.cir.99.24.3110","journal-title":"Circulation"},{"key":"4859_CR22","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1042\/0264-6021:3550289","volume":"355","author":"M Chen","year":"2001","unstructured":"Chen M, Narumiya S, Masaki T, Sawamura T (2001) Conserved C-terminal residues within the lectin-like domain of LOX-1 are essential for oxidized low-density-lipoprotein binding. Biochem J 355:289\u2013296. https:\/\/doi.org\/10.1042\/0264-6021:3550289","journal-title":"Biochem J"},{"key":"4859_CR23","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1038\/sj.ejhg.5201513","volume":"14","author":"E Trabetti","year":"2006","unstructured":"Trabetti E, Biscuola M, Cavallari U et al (2006) On the association of the oxidized LDL receptor 1 (OLR1) gene in patients with acute myocardial infarction or coronary artery disease. Eur J Hum Genet 14:127\u2013130. https:\/\/doi.org\/10.1038\/sj.ejhg.5201513","journal-title":"Eur J Hum Genet"},{"key":"4859_CR24","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1155\/2013\/716325","volume":"35","author":"A Pirillo","year":"2013","unstructured":"Pirillo A, Catapano AL (2013) Soluble lectin-like oxidized low density lipoprotein receptor-1 as a biochemical marker for atherosclerosis-related diseases. Dis Markers 35:413\u2013418. https:\/\/doi.org\/10.1155\/2013\/716325","journal-title":"Dis Markers"},{"key":"4859_CR25","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/j.cca.2014.11.016","volume":"440","author":"T Sawamura","year":"2015","unstructured":"Sawamura T, Wakabayashi I, Okamura T (2015) LOX-1 in atherosclerotic disease. Clin Chim Acta 440:157\u2013163. https:\/\/doi.org\/10.1016\/j.cca.2014.11.016","journal-title":"Clin Chim Acta"},{"key":"4859_CR26","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1016\/j.vph.2014.06.008","volume":"63","author":"W Zhao","year":"2014","unstructured":"Zhao W, Ma G, Chen X (2014) Lipopolysaccharide induced LOX-1 expression via TLR4\/MyD88\/ROS activated p38MAPK-NF-\u03baB pathway. Vascul Pharmacol 63:162\u2013172. https:\/\/doi.org\/10.1016\/j.vph.2014.06.008","journal-title":"Vascul Pharmacol"},{"key":"4859_CR27","doi-asserted-by":"publisher","first-page":"5323","DOI":"10.2741\/3084","volume":"13","author":"E Lubos","year":"2008","unstructured":"Lubos E, Handy DE, Loscalzo J (2008) Role of oxidative stress and nitric oxide in atherothrombosis. Front Biosci 13:5323\u20135344. https:\/\/doi.org\/10.2741\/3084","journal-title":"Front Biosci"},{"key":"4859_CR28","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1073\/pnas.97.1.360","volume":"97","author":"M Kakutani","year":"2000","unstructured":"Kakutani M, Masaki T, Sawamura T (2000) A platelet-endothelium interaction mediated by lectin-like oxidized low-density lipoprotein receptor-1. Proc Natl Acad Sci USA 97:360\u2013364. https:\/\/doi.org\/10.1073\/pnas.97.1.360","journal-title":"Proc Natl Acad Sci USA"},{"key":"4859_CR29","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1006\/bbrc.2001.4516","volume":"282","author":"M Chen","year":"2001","unstructured":"Chen M, Kakutani M, Naruko T et al (2001) Activation-dependent surface expression of LOX-1 in human platelets. Biochem Biophys Res Commun 282:153\u2013158. https:\/\/doi.org\/10.1006\/bbrc.2001.4516","journal-title":"Biochem Biophys Res Commun"},{"key":"4859_CR30","doi-asserted-by":"publisher","first-page":"2839","DOI":"10.1093\/eurheartj\/eht532","volume":"35","author":"A Akhmedov","year":"2014","unstructured":"Akhmedov A, Rozenberg I, Paneni F et al (2014) Endothelial overexpression of LOX-1 increases plaque formation and promotes atherosclerosis in vivo. Eur Heart J 35:2839\u20132848. https:\/\/doi.org\/10.1093\/eurheartj\/eht532","journal-title":"Eur Heart J"},{"key":"4859_CR31","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1161\/01.RES.0000113782.07824.BE","volume":"94","author":"J Chen","year":"2004","unstructured":"Chen J, Mehta JL, Haider N, Zhang X, Narula J, Li D (2004) Role of caspases in Ox-LDL-induced apoptotic cascade in human coronary artery endothelial cells. Circ Res 94:370\u2013376. https:\/\/doi.org\/10.1161\/01.RES.0000113782.07824.BE","journal-title":"Circ Res"},{"issue":"3","key":"4859_CR32","doi-asserted-by":"publisher","first-page":"e027540","DOI":"10.1161\/JAHA.122.027540","volume":"12","author":"AL Vavere","year":"2023","unstructured":"Vavere AL, Sinsakul M, Ongstad EL et al (2023) Lectin-like oxidized low-density lipoprotein receptor 1 inhibition in type 2 diabetes: phase 1 results. J Am Heart Assoc 12(3):e027540. https:\/\/doi.org\/10.1161\/JAHA.122.027540","journal-title":"J Am Heart Assoc"},{"key":"4859_CR33","doi-asserted-by":"publisher","first-page":"2889","DOI":"10.1161\/01.cir.101.25.2889","volume":"101","author":"D Li","year":"2000","unstructured":"Li D, Mehta JL (2000) Antisense to LOX-1 inhibits oxidized LDL-mediated upregulation of monocyte chemoattractant protein-1 and monocyte adhesion to human coronary artery endothelial cells. Circulation 101:2889\u20132895. https:\/\/doi.org\/10.1161\/01.cir.101.25.2889","journal-title":"Circulation"},{"key":"4859_CR34","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1161\/ATVBAHA.120.315421","volume":"41","author":"J Barreto","year":"2021","unstructured":"Barreto J, Karathanasis SK, Remaley A, Sposito AC (2021) Role of LOX-1 (lectin-like oxidized low-density lipoprotein receptor 1) as a cardiovascular risk predictor: mechanistic insight and potential clinical use. Arterioscler Thromb Vasc Biol 41:153\u2013166. https:\/\/doi.org\/10.1161\/ATVBAHA.120.315421","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"4859_CR35","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1016\/j.atherosclerosis.2008.04.002","volume":"202","author":"H Mitsuoka","year":"2009","unstructured":"Mitsuoka H, Kume N, Hayashida K et al (2009) Interleukin 18 stimulates release of soluble lectin-like oxidized LDL receptor-1 (sLOX-1). Atherosclerosis 202:176\u2013182. https:\/\/doi.org\/10.1016\/j.atherosclerosis.2008.04.002","journal-title":"Atherosclerosis"},{"key":"4859_CR36","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1038\/gt.2011.133","volume":"19","author":"J Lu","year":"2012","unstructured":"Lu J, Wang X, Wang W et al (2012) LOX-1 abrogation reduces cardiac hypertrophy and collagen accumulation following chronic ischemia in the mouse. Gene Ther 19:522\u2013531. https:\/\/doi.org\/10.1038\/gt.2011.133","journal-title":"Gene Ther"},{"key":"4859_CR37","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1097\/00029330-200703010-00015","volume":"120","author":"XP Chen","year":"2007","unstructured":"Chen XP, Du GH (2007) Lectin-like oxidized low-density lipoprotein receptor-1: protein, ligands, expression and pathophysiological significance. Chin Med J 120:421\u2013635","journal-title":"Chin Med J"},{"key":"4859_CR38","doi-asserted-by":"publisher","first-page":"147","DOI":"10.2174\/157489007780832506","volume":"2","author":"L Vecchione","year":"2007","unstructured":"Vecchione L, Gargiulo E, Borgiani P et al (2007) Genotyping OLR1 gene: a genomic biomarker for cardiovascular diseases. Recent Pat Cardiovasc Drug Discov 2:147\u2013151. https:\/\/doi.org\/10.2174\/157489007780832506","journal-title":"Recent Pat Cardiovasc Drug Discov"},{"key":"4859_CR39","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1016\/j.str.2005.03.016","volume":"13","author":"I Ohki","year":"2005","unstructured":"Ohki I, Ishigaki T, Oyama T et al (2005) Crystal structure of human lectin-like, oxidized low-density lipoprotein receptor 1 ligand binding domain and its ligand recognition mode to OxLDL. Structure 13:905\u2013917. https:\/\/doi.org\/10.1016\/j.str.2005.03.016","journal-title":"Structure"},{"key":"4859_CR40","doi-asserted-by":"publisher","first-page":"1273","DOI":"10.1242\/jcs.114.7.1273","volume":"114","author":"X Shi","year":"2001","unstructured":"Shi X, Niimi S, Ohtani T, Machida S (2001) Characterization of residues and sequences of the carbohydrate recognition domain required for cell surface localization and ligand binding of human lectin-like oxidized LDL receptor. J Cell Sci 114:1273\u20131282. https:\/\/doi.org\/10.1242\/jcs.114.7.1273","journal-title":"J Cell Sci"},{"key":"4859_CR41","doi-asserted-by":"publisher","first-page":"928","DOI":"10.1073\/pnas.0335507100","volume":"100","author":"NG Seidah","year":"2003","unstructured":"Seidah NG, Benjannet S, Wickham L, Marcinkiewicz J, Jasmin SB, Stifani S et al (2003) The secretory proprotein convertase neural apoptosis-regulated convertase 1 (NARC-1): liver regeneration and neuronal differentiation. Proc Natl Acad Sci U S A 100:928\u2013933","journal-title":"Proc Natl Acad Sci U S A"},{"key":"4859_CR42","doi-asserted-by":"publisher","first-page":"2995","DOI":"10.1172\/JCI29383","volume":"116","author":"TA Lagace","year":"2006","unstructured":"Lagace TA, Curtis DE, Garuti R et al (2006) Secreted PCSK9 decreases the number of LDL receptors in hepatocytes and livers of parabiotic mice. J Clin Invest 116:2995\u20133005","journal-title":"J Clin Invest"},{"key":"4859_CR43","doi-asserted-by":"publisher","first-page":"8279","DOI":"10.1074\/jbc.M112.421370","volume":"288","author":"T Kosenko","year":"2013","unstructured":"Kosenko T, Golder M, Leblond G, Weng W, Lagace TA (2013) Low density lipoprotein binds to proprotein convertase subtilisin\/kexin type-9 (PCSK9) in human plasma and inhibits PCSK9-mediated low density lipoprotein receptor degradation. J Biol Chem 288:8279\u20138288","journal-title":"J Biol Chem"},{"issue":"4","key":"4859_CR44","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1093\/cvr\/cvv178","volume":"107","author":"Z Ding","year":"2015","unstructured":"Ding Z, Liu S, Wang X et al (2015) Cross-talk between LOX-1 and PCSK9 in vascular tissues. Cardiovasc Res 107(4):556\u201367. https:\/\/doi.org\/10.1093\/cvr\/cvv178","journal-title":"Cardiovasc Res"},{"key":"4859_CR45","doi-asserted-by":"publisher","first-page":"1583","DOI":"10.1080\/15384101.2015.1026486","volume":"14","author":"S Biocca","year":"2015","unstructured":"Biocca S, Iacovelli F, Matarazzo S et al (2015) Molecular mechanism of statin-mediated LOX-1 inhibition. Cell Cycle 14:1583\u20131595","journal-title":"Cell Cycle"},{"key":"4859_CR46","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1038\/s42004-020-0321","volume":"3","author":"G Schnapp","year":"2020","unstructured":"Schnapp G, Neubauer H, B\u00fcttner FH et al (2020) A small-molecule inhibitor of lectin-like oxidized LDL receptor-1 acts by stabilizing an inactive receptor tetramer state. Commun Chem 3:75. https:\/\/doi.org\/10.1038\/s42004-020-0321","journal-title":"Commun Chem"},{"issue":"1","key":"4859_CR47","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1161\/ATVBAHA.120.315421","volume":"41","author":"J Barreto","year":"2021","unstructured":"Barreto J, Karathanasis SK, Remaley A, Sposito AC, Role of LOX-1 (2021) (Lectin-like oxidized low-density lipoprotein receptor 1) as a cardiovascular risk predictor: mechanistic insight and potential clinical use. Arterioscler Thromb Vasc Biol 41(1):153\u2013166. https:\/\/doi.org\/10.1161\/ATVBAHA.120.315421","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"2","key":"4859_CR48","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1038\/s41419-018-1279-1","volume":"10","author":"S Pucci","year":"2019","unstructured":"Pucci S, Polidoro C, Greggi C et al (2019) Pro-oncogenic action of LOX-1 and its splice variant LOX-1\u03944 in breast cancer phenotypes. Cell Death Dis 10(2):53. https:\/\/doi.org\/10.1038\/s41419-018-1279-1","journal-title":"Cell Death Dis"},{"key":"4859_CR49","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1016\/j.yjmcc.2007.11.017","volume":"44","author":"S Biocca","year":"2008","unstructured":"Biocca S, Filesi I, Mango R et al (2008) The splice variant LOXIN inhibits LOX-1 receptor function through hetero-oligomerization. J Mol Cell Cardiol 44:561\u2013570. https:\/\/doi.org\/10.1016\/j.yjmcc.2007.11.017","journal-title":"J Mol Cell Cardiol"},{"issue":"13","key":"4859_CR50","doi-asserted-by":"publisher","first-page":"7329","DOI":"10.3390\/ijms23137329","volume":"23","author":"C Reyes","year":"2022","unstructured":"Reyes C, Nova-Lamperti E, Duran-Sandoval D et al (2022) Loxin reduced the inflammatory response in the liver and the aortic fatty streak formation in mice fed with a high-fat diet. Int J Mol Sci 23(13):7329. https:\/\/doi.org\/10.3390\/ijms23137329","journal-title":"Int J Mol Sci"},{"key":"4859_CR51","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1097\/FJC.0000000000000358","volume":"67","author":"C Veas","year":"2016","unstructured":"Veas C, Jara C, Willis ND et al (2016) Overexpression of LOXIN protects endothelial progenitor cells from apoptosis induced by oxidized low density lipoprotein. J Cardiovasc Pharmacol 67:326\u2013335. https:\/\/doi.org\/10.1097\/FJC.0000000000000358","journal-title":"J Cardiovasc Pharmacol"},{"key":"4859_CR52","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1016\/j.carpath.2010.08.007","volume":"20","author":"SJ White","year":"2011","unstructured":"White SJ, Sala-Newby GB, Newby AC (2011) Overexpression of scavenger receptor LOX-1 in endothelial cells promotes atherogenesis in the ApoE(-\/-) mouse model. Cardiovasc Pathol 20:369\u2013373. https:\/\/doi.org\/10.1016\/j.carpath.2010.08.007","journal-title":"Cardiovasc Pathol"},{"key":"4859_CR53","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1161\/01.RES.0000174563.62625.8e","volume":"97","author":"R Mango","year":"2005","unstructured":"Mango R, Biocca S, del Vecchio F et al (2005) In vivo and in vitro studies support that a new splicing isoform of OLR1 gene is protective against acute myocardial infarction. Circ Res 97:152\u2013158. https:\/\/doi.org\/10.1161\/01.RES.0000174563.62625.8e","journal-title":"Circ Res"},{"key":"4859_CR54","doi-asserted-by":"publisher","first-page":"1187","DOI":"10.1261\/rna.049890.115","volume":"21","author":"JR Tejedor","year":"2015","unstructured":"Tejedor JR, Tilgner H, Iannone C, Guig\u00f3 R, Valc\u00e1rcel J (2015) Role of six single nucleotide polymorphisms, risk factors in coronary disease, in OLR1 alternative splicing. RNA 21:1187\u20131202. https:\/\/doi.org\/10.1261\/rna.049890.115","journal-title":"RNA"},{"key":"4859_CR55","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1159\/000330412","volume":"119","author":"Y Cheng","year":"2011","unstructured":"Cheng Y, Wei Y, Li W et al (2011) Associations between oxidized-lipoprotein receptor 1 G501C and 3\u2019-UTR-C188T polymorphisms and coronary artery disease: a meta-analysis. Cardiology 119:90\u201395. https:\/\/doi.org\/10.1159\/000330412","journal-title":"Cardiology"},{"key":"4859_CR56","doi-asserted-by":"publisher","first-page":"321","DOI":"10.17219\/acem\/68395","volume":"27","author":"O Kurnaz-Gomleksiz","year":"2018","unstructured":"Kurnaz-Gomleksiz O, Kucukhuseyin O, Ozkok E, Bugra Z, Ozturk O, Yilmaz-Aydogan H (2018) Are IVS4 SNPs of OLR1 gene associated with coronary artery disease: Is there a linkage between IVS4 SNPs? Adv Clin Exp Med 27:321\u2013326. https:\/\/doi.org\/10.17219\/acem\/68395","journal-title":"Adv Clin Exp Med"},{"key":"4859_CR57","doi-asserted-by":"publisher","first-page":"391","DOI":"10.2459\/JCM.0b013e3283624251","volume":"15","author":"A Cappelletti","year":"2014","unstructured":"Cappelletti A, Zanussi M, Mazzavillani M et al (2014) Association of LOXIN, a new functional splicing isoform of the OLR1 gene, with severity and prognostic localization of critical coronary artery stenoses. J Cardiovasc Med (Hagerstown) 15:391\u2013396. https:\/\/doi.org\/10.2459\/JCM.0b013e3283624251","journal-title":"J Cardiovasc Med (Hagerstown)"},{"key":"4859_CR58","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.1016\/j.clinbiochem.2011.05.027","volume":"44","author":"R Gambino","year":"2011","unstructured":"Gambino R, Bo S, Musso G, Pagano G, Cassader M (2011) Loxin polymorphism is associated with increased resistin levels and with oxidative status. Clin Biochem 44:1015\u20131017. https:\/\/doi.org\/10.1016\/j.clinbiochem.2011.05.027","journal-title":"Clin Biochem"},{"key":"4859_CR59","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1016\/j.brainres.2006.08.091","volume":"1121","author":"H Hattori","year":"2006","unstructured":"Hattori H, Sonoda A, Sato H et al (2006) G501C polymorphism of oxidized LDL receptor gene (OLR1) and ischemic stroke. Brain Res 1121:246\u2013249. https:\/\/doi.org\/10.1016\/j.brainres.2006.08.091","journal-title":"Brain Res"},{"key":"4859_CR60","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1016\/s0006-291x(03)00326-7","volume":"303","author":"M Tatsuguchi","year":"2003","unstructured":"Tatsuguchi M, Furutani M, Hinagata J et al (2003) Oxidized LDL receptor gene (OLR1) is associated with the risk of myocardial infarction. Biochem Biophys Res Commun 303:247\u2013250. https:\/\/doi.org\/10.1016\/s0006-291x(03)00326-7","journal-title":"Biochem Biophys Res Commun"},{"key":"4859_CR61","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1136\/jmg.40.12.933","volume":"40","author":"R Mango","year":"2003","unstructured":"Mango R, Clementi F, Borgiani P et al (2003) Association of single nucleotide polymorphisms in the oxidised LDL receptor 1 (OLR1) gene in patients with acute myocardial infarction. J Med Genet 40:933\u2013936. https:\/\/doi.org\/10.1136\/jmg.40.12.933","journal-title":"J Med Genet"},{"key":"4859_CR62","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1002\/clc.4960271112","volume":"27","author":"R Ohmori","year":"2004","unstructured":"Ohmori R, Momiyama Y, Nagano M et al (2004) An oxidized low-density lipoprotein receptor gene variant is inversely associated with the severity of coronary artery disease. Clin Cardiol 27:641\u2013644. https:\/\/doi.org\/10.1002\/clc.4960271112","journal-title":"Clin Cardiol"},{"key":"4859_CR63","doi-asserted-by":"publisher","first-page":"e31086","DOI":"10.1371\/journal.pone.0031086","volume":"7","author":"IM Predazzi","year":"2009","unstructured":"Predazzi IM, Norata GD, Vecchione L et al (2009) Association between OLR1 K167N SNP and intima media thickness of the common carotid artery in the general population. PLoS ONE 7:e31086. https:\/\/doi.org\/10.1371\/journal.pone.0031086","journal-title":"PLoS ONE"},{"key":"4859_CR64","doi-asserted-by":"publisher","first-page":"e4648","DOI":"10.1371\/journal.pone.0004648","volume":"4","author":"S Biocca","year":"2009","unstructured":"Biocca S, Falconi M, Filesi I et al (2009) Functional analysis and molecular dynamics simulation of LOX-1 K167N polymorphism reveal alteration of receptor activity. PLoS ONE 4:e4648. https:\/\/doi.org\/10.1371\/journal.pone.0004648","journal-title":"PLoS ONE"},{"key":"4859_CR65","doi-asserted-by":"publisher","first-page":"18224","DOI":"10.1038\/srep18224","volume":"5","author":"A Au","year":"2015","unstructured":"Au A, Griffiths LR, Cheng KK, Wee Kooi C, Irene L, Wei L (2015) The influence of OLR1 and PCSK9 gene polymorphisms on ischemic stroke: evidence from a meta-analysis. Sci Rep 5:18224. https:\/\/doi.org\/10.1038\/srep18224","journal-title":"Sci Rep"},{"key":"4859_CR66","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1186\/1476-511X-13-55","volume":"13","author":"X Liu","year":"2014","unstructured":"Liu X, Zhu RX, Li L, He ZY (2014) Association of LOX-1 gene polymorphisms with cerebral infarction in northern Chinese Han population. Lipids Health Dis 13:55. https:\/\/doi.org\/10.1186\/1476-511X-13-55","journal-title":"Lipids Health Dis"},{"key":"4859_CR67","doi-asserted-by":"publisher","first-page":"391","DOI":"10.3233\/NRE-130860","volume":"32","author":"J Zhang","year":"2013","unstructured":"Zhang J, Yin C, Zhang Y, Zhao L, Fu H, Feng J (2013) The role of OLR1 polymorphisms in determining the risk and prognosis of ischemic stroke in a Chinese population. NeuroRehabilitation 32:391\u2013396. https:\/\/doi.org\/10.3233\/NRE-130860","journal-title":"NeuroRehabilitation"},{"key":"4859_CR68","doi-asserted-by":"publisher","unstructured":"Novelli G, Borgiani P, Mango R, Lauro R, Romeo F (2007) Further evidence that polymorphisms of the OLR1 gene are associated with susceptibility to coronary artery disease and myocardial infarction. Nutr Metab Cardiovasc Dis 17:e7\u20138; author reply e9\u201310. https:\/\/doi.org\/10.1016\/j.numecd.2006.12.006","DOI":"10.1016\/j.numecd.2006.12.006"},{"key":"4859_CR69","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1016\/j.hrtlng.2021.01.015","volume":"50","author":"P Salehipour","year":"2021","unstructured":"Salehipour P, Rezagholizadeh F, Mahdiannasser M, Kazerani R, Modarressi MH (2021) Association of OLR1 gene polymorphisms with the risk of coronary artery disease: a systematic review and meta-analysis. Heart Lung 50:334\u2013343. https:\/\/doi.org\/10.1016\/j.hrtlng.2021.01.015","journal-title":"Heart Lung"},{"issue":"4","key":"4859_CR70","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1080\/10641963.2017.1384485","volume":"40","author":"N Kaur","year":"2018","unstructured":"Kaur N, Singh J, Reddy S (2018) Interaction between ALOX15 polymorphisms and coronary artery disease in North Indian population. Clin Exp Hypertens 40(4):398\u2013405. https:\/\/doi.org\/10.1080\/10641963.2017.1384485","journal-title":"Clin Exp Hypertens"},{"key":"4859_CR71","doi-asserted-by":"publisher","first-page":"572","DOI":"10.5551\/jat.36327","volume":"24","author":"X Guo","year":"2017","unstructured":"Guo X, Xiang Y, Yang H, Xiangdong LY, Peng Guo R (2017) Association of the LOX-1 rs1050283 polymorphism with risk for atherosclerotic cerebral infarction and its effect on sLOX-1 and LOX-1 expression in a Chinese population. J Atheroscler Thromb 24:572\u2013582. https:\/\/doi.org\/10.5551\/jat.36327","journal-title":"J Atheroscler Thromb"},{"issue":"3","key":"4859_CR72","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1089\/gtmb.2019.0209","volume":"24","author":"Q Zhang","year":"2020","unstructured":"Zhang Q, Chu Y, Jin G, Dai J, Kang H (2020) Association between LOX-1, LAL, and ACAT1 gene single nucleotide polymorphisms and carotid plaque in a Northern Chinese population genet test. Mol Biomark 24(3):138\u2013144. https:\/\/doi.org\/10.1089\/gtmb.2019.0209","journal-title":"Mol Biomark"},{"issue":"2","key":"4859_CR73","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1177\/10815589221141831","volume":"71","author":"SB Sahin","year":"2023","unstructured":"Sahin SB, Nalkiran I, Ayaz T et al (2023) Genetic variations in OLR1 gene associated with PCOS and atherosclerotic risk factors. J Invest Med 71(2):113\u2013123. https:\/\/doi.org\/10.1177\/10815589221141831","journal-title":"J Invest Med"},{"issue":"5","key":"4859_CR74","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1515\/tjb-2021-0214","volume":"47","author":"E Recep","year":"2022","unstructured":"Recep E, Bayoglu B, Arslan C, Goksedef D, Ipek G (2022) Roles of OLR1 and IL17A variants on clinical phenotypes of Turkish patients undergoing coronary artery bypass surgery. Turk J Biochem 47(5):571\u2013579. https:\/\/doi.org\/10.1515\/tjb-2021-0214","journal-title":"Turk J Biochem"},{"issue":"2","key":"4859_CR75","doi-asserted-by":"publisher","first-page":"1175","DOI":"10.15562\/bmj.v12i2.4221","volume":"12","author":"Y Indrayana","year":"2023","unstructured":"Indrayana Y, Yusuf I, Bukhari A, Mappangara I, Harahap HS (2023) LOX-1 rs1050283 TT genotype is associated with the severity of peripheral artery disease: a cross-sectional study in Mataram, Indonesia. Bali Med J 12(2):1175\u20131180. https:\/\/doi.org\/10.15562\/bmj.v12i2.4221","journal-title":"Bali Med J"},{"issue":"4","key":"4859_CR76","doi-asserted-by":"publisher","first-page":"537","DOI":"10.52547\/rbmb.10.4.537","volume":"10","author":"HSE Mohammed","year":"2022","unstructured":"Mohammed HSE, Kamal MM, ElBadre HM et al (2022) Lectin-like OLR1 3\u2019UTR Rs1050286 gene polymorphism and plasma oxidized-LDL in coronary artery disease and their relation to cardiovascular risk and outcomes. Rep Biochem Mol Biol 10(4):537\u2013553. https:\/\/doi.org\/10.52547\/rbmb.10.4.537","journal-title":"Rep Biochem Mol Biol"}],"container-title":["Molecular and Cellular Biochemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11010-023-04859-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11010-023-04859-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11010-023-04859-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,3]],"date-time":"2024-09-03T19:06:55Z","timestamp":1725390415000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11010-023-04859-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10,3]]},"references-count":76,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2024,9]]}},"alternative-id":["4859"],"URL":"https:\/\/doi.org\/10.1007\/s11010-023-04859-0","relation":{},"ISSN":["0300-8177","1573-4919"],"issn-type":[{"value":"0300-8177","type":"print"},{"value":"1573-4919","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,10,3]]},"assertion":[{"value":"30 June 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 September 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 October 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have no relevant financial or non-financial interests to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}